Daffodil Biochem Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.92 M
- Company Age 31 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -8.28%
- Ebitda -8.28%
- Net Worth -0.19%
- Total Assets -0.19%
About Daffodil Biochem
Daffodil Biochem Private Limited (DBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 1993 and has a history of 31 years and four months. Its registered office is in Ahmedabad, Gujarat.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.92 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Patel, Kushal Patel, and Shailesh Patel serve as directors at the Company.
Company Details
- Location Ahmedabad, Gujarat
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230GJ1993PTC020434
- Company No.
020434
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Daffodil Biochem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Patel  | Director | 15-Dec-1996 | Current |
| Kushal Patel | Director | 22-Jul-2023 | Current |
| Shailesh Patel | Director | 15-Nov-2005 | Current |
Financial Performance of Daffodil Biochem.
Daffodil Biochem Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 8.28% decrease in profit. The company's net worth dipped by a decrease of 0.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daffodil Biochem?
Unlock access to Daffodil Biochem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Daffodil Pharmaceuticals Private LimitedJitendra Patel is a mutual person
- Daffodil Pharmachem Private Limited
Jitendra Patel and Kushal Patel are mutual person
Daffodil Biosynth Private LimitedJitendra Patel and Kushal Patel are mutual person
- Daffocare Research Laboratory Llp
Kushal Patel is a mutual person
- Bridgecare F And D Private Limited
Kushal Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Daffodil Biochem?
Unlock and access historical data on people associated with Daffodil Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daffodil Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffodil Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.